Karen Blum

Alcon Executives Lay Out a Road Map for after the Spin-off

Alcon Executives Lay Out a Road Map for after the Spin-off

With a management team experienced in healthcare and ophthalmology, and market trends like aging increasing the need for ophthalmic care and a rich pipeline of innovative products, Alcon is well poised to succeed as a stand-alone company, company executives told investors and analysts last month in New York. “Does Alcon...

Read More
Seven Steps for Walking the Reimbursement Maze

Seven Steps for Walking the Reimbursement Maze

WASHINGTON, DC – Getting insurers to reimburse for novel ophthalmic devices and procedures has been getting harder, but by planning early, involving the right employees, and having a defined path to reimbursement, companies can still achieve success. This was the advice given by panelists at OIS@ASCRS 2018. Here are seven...

Read More
Keeping the MIGS Explosion in Perspective

Keeping the MIGS Explosion in Perspective

WASHINGTON, DC – When Stanford University ophthalmology professor Kuldev Singh, MD, MPH, underwent medical training 25 years ago, there were maybe five to six non-pharmaceutical treatment options to manage glaucoma. Today, there are some 17 different approaches, he said during a session on microincisional glaucoma surgery (MIGS) at the OIS@ASCRS...

Read More
Workshop’s Message: Handle Data with Care

Workshop’s Message: Handle Data with Care

GAITHERSBURG, MD – Digital Health devices can help detect eye disease in various health-care settings, although ophthalmic practices need to carefully monitor data they generate, and primary-care practices and patients using such technologies require extra instruction to use them safely and effectively, a panel of eye experts said here. Ophthalmic...

Read More
Where Digital Health Fits in Ophthalmology

Panel: Where Digital Health Fits in Ophthalmology

GAITHERSBURG, MD – Trusting Digital Health devices to identify slow-progressing eye diseases like glaucoma or diabetic retinopathy may make sense, but trained ophthalmologists, not machines, are still best suited to diagnose quick-moving, sight-threatening conditions such as retinopathy of prematurity (ROP), a panel of eye experts said here. Diabetic retinopathy is...

Read More
Learn how the Ophthalmic Digital Health workshop fits with the FDA Commissioner's vision

Workshop Part of Gottlieb’s Digital Plan

When Food and Drug Administration Commissioner Scott Gottlieb, MD, announced a new agency-wide initiative last summer called the Digital Health Innovation Plan, the goal was to foster “innovation at the intersection of medicine and digital health technology.” That includes issuing new guidance documents on low-risk digital health products and a...

Read More